INTS logo

Intensity Therapeutics, Inc.

INTS
Healthcare|Biotechnology|US
$3.00
-0.10 (-3.23%)
DCF Value
$8.35
Tangible Book / Share
$2.35
Cash / Share
$2.61
Next Earnings Report
Mar 18, 2027
EPS est. -$0.75
Financing Filings (last 12 months)
2
Shelf registrations / offering prospectuses — latest Mar 23, 2026 (424B5). Possible dilution.

Upcoming Data Readouts (1)

Dec 2027
Est. completion
P3Sarcoma,Soft Tissue
A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)
NCT06263231n=333

Recent Press Releases

Intensity Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
Nov 5, 2026 · PRNewsWire
Intensity Therapeutics to Announce Third Quarter 2026 Financial Results on November 5, 2026
Oct 30, 2026 · PRNewsWire
Intensity Therapeutics, Inc. to Present INVINCIBLE-4 Neoadjuvant Triple-Negative Breast Cancer Study Data for the First Seven (7) Patients After INT230-6 Treatment (Cohort A) in an ePoster Presentation at the European Society of Medical Oncology (ESMO) Meeting
Oct 23, 2026 · PRNewsWire
Intensity Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Sep 8, 2026 · PRNewsWire
Intensity Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 11, 2026 · PRNewsWire

SEC Filings (73)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 5, 20268-KMaterial eventDocumentIndex
Nov 5, 202610-QQuarterly reportDocumentIndex
Aug 11, 20268-KMaterial eventDocumentIndex
Aug 11, 202610-QQuarterly reportDocumentIndex
Jul 8, 2026S-8Employee stock planDocumentIndex
Jun 16, 20268-KMaterial eventDocumentIndex
May 7, 20268-KMaterial eventDocumentIndex
May 7, 202610-QQuarterly reportDocumentIndex
Apr 30, 2026ARSAnnual report to holdersDocumentIndex
Apr 30, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 30, 2026DEF 14AProxy / shareholder voteDocumentIndex
Mar 27, 20268-KMaterial eventDocumentIndex
Mar 27, 202610-KAnnual reportDocumentIndex
Mar 23, 20268-KMaterial eventDocumentIndex
Mar 23, 2026424B5Offering prospectusDocumentIndex
Mar 6, 20268-KMaterial eventDocumentIndex
Mar 5, 20268-KMaterial eventDocumentIndex
Feb 13, 20268-KMaterial eventDocumentIndex
Jan 23, 2026S-8Employee stock planDocumentIndex
Dec 5, 20258-KMaterial eventDocumentIndex
Dec 4, 20258-KMaterial eventDocumentIndex
Dec 4, 2025424B5Offering prospectusDocumentIndex
Nov 6, 20258-KMaterial eventDocumentIndex
Nov 6, 202510-QQuarterly reportDocumentIndex
Nov 3, 2025424B5Offering prospectusDocumentIndex
Oct 31, 20258-KMaterial eventDocumentIndex
Oct 23, 20258-KMaterial eventDocumentIndex
Sep 10, 20258-KMaterial eventDocumentIndex
Sep 9, 2025DEFA14AProxy / shareholder voteDocumentIndex
Sep 9, 2025DEF 14AProxy / shareholder voteDocumentIndex
Aug 28, 2025PRE 14AProxy / shareholder voteDocumentIndex
Aug 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Aug 12, 20258-KMaterial eventDocumentIndex
Aug 7, 20258-KMaterial eventDocumentIndex
Aug 7, 202510-QQuarterly reportDocumentIndex
Aug 4, 20258-KMaterial eventDocumentIndex
Jul 18, 20258-KMaterial eventDocumentIndex
Jul 9, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Jun 27, 2025S-8Employee stock planDocumentIndex
Jun 18, 2025424B5Offering prospectusDocumentIndex